Objective The role of oxidative stress in IgA nephropathy (IgAN), the most common type of primary glomerulonephritis, is unknown. We evaluated the clinical significance of serum levels of oxidative stress markers, thioredoxin (TRX) and manganese superoxide dismutase (MnSOD), in patients with IgAN. Methods Forty-eight patients with histologically confirmed IgAN and 14 healthy subjects were enrolled in this study. Serum samples from 14 IgAN patients were obtained after tonsillectomy, a procedure hypothesized to be an effective treatment for IgAN. Results Serum TRX levels were significantly higher in patients with IgAN than in healthy subjects (mean [ng/mL]; 49.5 vs.14.4, p<0.001). Serum TRX levels are positively correlated with blood urea nitrogen, serum uric acid and proteinuria, and negatively with estimated glomerular filtration rate (eGFR). In addition, serum TRX levels gradually increased as the severity of renal histology increased. High levels of serum TRX were significantly decreased after tonsillectomy in patients with IgAN (mean [ng/mL]; 55.5 to 41.1, p=0.02). In contrast, serum MnSOD levels did not differ between IgAN patients and healthy subjects, and these levels did not change after tonsillectomy in IgAN patients. Conclusion Serum TRX is associated with IgAN, and tonsillectomy may decrease oxidative stress in IgAN patients, leading to clinical improvement.
Introduction
Immunoglobulin A (IgA) nephropathy (IgAN) is the most common glomerulonephritis in the world (1) . Although this disease was once considered to have a good prognosis, it has more recently been observed that 30-40% of IgAN patients progress to end-stage renal disease (ESRD) within 20 years. Thus, analysis of the mechanism of occurrence or progression of IgAN is important to reduce or prevent the number of patients with ESRD.
One type of IgAN pathogenesis is associated with polymeric IgA of the IgA1 subclass, which can react to the glomerular mesangium. It was also suggested that the nephrotoxicity of aberrantly glycosylated IgA1 in IgAN is enhanced in the presence of oxidative stress (2) . In addition, antioxidants such as vitamin E supplements were reported to reduce the incidence of hematuria and proteinuria in experimental IgAN rats (3). Chen et al reported that circulating IgA isolated from IgAN patients significantly enhanced superoxide production of mesangial cells (4) . These results indicate that oxidative stress is associated with IgAN, but oxidative stress in patients with IgAN has not been fully evaluated.
Thioredoxin (TRX), a redox-active protein with two cysteine residues in its active site, is induced by many forms of oxidative stress (5, 6) , and serum TRX levels are thought to be a clinically useful oxidative stress marker. Serum or plasma levels of TRX are reported to be elevated in patients with several diseases, including nonalcoholic steatohepatitis (7) and pancreatic cancer (8) . In addition, immunohistochemical analysis has demonstrated that TRX is distributed throughout many organs and tissues, including the liver and kidney (5) . Therefore, serum TRX levels may be a valuable biomarker in IgAN patients.
Manganese superoxide dismutase (MnSOD) is also considered to be an oxidative stress marker. We previously reported that serum MnSOD levels did not correlate with serum TRX levels in patients with hepatitis C virus-related hepatocellular carcinoma, although the levels of both were higher in these patients in comparison to healthy subjects (9) . However, the clinical significance of serum MnSOD levels in IgAN patients has not been investigated.
Various therapies for IgAN have been attempted; glucocorticoid therapy improves proteinurea and prognosis in patients with mild to moderate IgAN (10-13), and Hotta et al reported that combination therapy including tonsillectomy and steroid pulse therapy led to remission of IgAN (14) . However, there has been no report regarding the association between oxidative stress and tonsillectomy in IgAN patients.
In this study, we determined the serum levels of TRX and MnSOD in IgAN patients, and evaluated the clinical significance of these levels in patients who underwent tonsillectomy.
Materials and Methods

Patients
This retrospective study includes 48 IgAN patients (20 males and 28 females; mean age, 34.0 years; range 13-68 years) who had undergone renal biopsy for evaluation of proteinuria or hematuria. Among these IgAN patients, 38 underwent tonsillectomy and serum samples of 14 patients were obtained 6 to 33 days after tonsillectomy without additional corticosteroid treatment. Fourteen healthy volunteers (7 males and 7 females, age 36.6 years; range 31-51 years) also enrolled in this study. Table 1 [4.6] ) were treated with both steroid pulse therapy and tonsillectomy. One patient had undergone a tonsillectomy 20 years before enrollment in this study and was treated with steroid pulse therapy after measurement of serum TRX and MnSOD levels.
Histological classification
The histological classification of the Special Study Group (IgA nephropathy) on Progressive Glomerular Disease in Japan, which is a divided into four groups (15), was used. Urinary occult blood in the urine was measured as a semiqualitative method, and estimated glomerular filtration rate (eGFR) was calculated using the new Japanese eGFR formula (16) . The severity of glomerular lesions was classified using the index of mesangial cell proliferation (IMP) (17) .
Measurement of serum TRX, serum MnSOD, and urinary TRX
Blood and urinary samples were collected at the time of renal biopsy. Blood samples were also obtained at 6 to 33 days after tonsillectomy in 14 patients with IgAN. Blood samples were obtained only from patients who had never received steroid-based treatment, even when the samples were obtained after tonsillectomy. All samples were stored at -80 until analysis.
Serum and urinary TRX levels were measured by TRX enzyme-linked immunosorbent assay (ELISA) kit (Redox Bio Science Inc., Kyoto, Japan). Serum MnSOD levels were measured by ELISA (Young In Frontier Co., Ltd., Seoul, Korea).
Statistical analysis
All results are shown as means ± standard errors (SEs). 
Results
Serum TRX and MnSOD levels in patients with IgA nephropathy
Serum TRX levels in IgAN patients were significantly higher (mean ± SE, 49.5 ± 4.4 ng/mL) than those in healthy volunteers (14.4 ± 1.9 ng/mL); [p<0.001, (Fig. 1A) ]. In contrast, serum levels of MnSOD, which may be another marker of oxidative stress (18) , did not differ between IgAN patients and healthy volunteers (48.8 ± 2.1 vs. 54.8 ± 6.4 ng/mL, p=0.53) (Fig. 1B) .
Serum TRX levels and clinical data
The correlations between serum TRX levels and values for numerous clinical parameters were examined in IgAN patients (Table 2 ). Blood urea nitrogen (BUN), serum uric acid, and urinary protein were positively correlated with serum TRX levels in IgAN patients, and eGFR was negatively correlated with serum TRX levels, although these correlations were weak. In contrast, urinary TRX divided by urinary creatinine (u-TRX/u-Cr) was not correlated with serum TRX levels ( Table 2 ).
In addition, because the median value of serum TRX in patients with IgAN was 40.6 (ng/mL) in this study, the clinical data for IgAN patients with serum TRX levels !40 ng/mL (high-TRX group) were compared to those of patients with serum TRX levels <40 ng/mL (low-TRX group). As shown in Table 3 , serum BUN, creatinine, uric acid, and urinary protein were significantly higher, and eGFR was lower in the high-TRX group compared to the low-TRX group. These results indicate that serum TRX levels were associated with renal function; high serum TRX levels indicated impaired renal function.
Correlation between serum TRX levels and histological classification of IgA nephropathy
Serum TRX levels in IgAN patients tended to increase in parallel with the severity of the histological classification of nephropathy as determined by the Japanese classification (Fig. 2) , although the difference was not significant. In addition, the prevalence of histological group 4 and IMP score were significantly higher in the high-TRX group than in the low-TRX group (Table 3) .
Serum TRX and MnSOD levels in patients with IgAN after tonsillectomy
Among 38 IgAN patients who underwent tonsillectomy after enrollment in this study, serum samples were obtained from 14 patients both before and after tonsillectomy. Serum TRX levels were significantly decreased following tonsillectomy (mean ± SE, 58.3 ± 8.3 ng/mL to 42.4 ± 7.2 ng/mL, p=0.01) (Fig. 3) . Serum TRX levels in 11 of these 14 patients decreased after tonsillectomy and the levels in the other three patients increased. In contrast, there was no significant change in serum MnSOD levels in IgAN patients before and after tonsillectomy (45.4 ± 3.5 ng/mL to 49.0 ± 3.0 ng/mL).
Discussion
This study demonstrated that serum TRX levels in IgAN patients were significantly higher than those in healthy volunteers. Serum TRX levels were also weakly but statistically correlated with eGFR, BUN, UA, and urinary protein. The levels of these markers tended to gradually increase with increasing severity of histologically assessed nephropathy, and the prevalence of histological group 4 nephropathy and IMP score were significantly higher in IgAN patients with TRX levels !40 ng/mL than in patients with TRX levels <40 ng/ mL. In addition, high serum TRX levels in IgAN patients decreased significantly after tonsillectomy. Serum TRX levels are thought to be an indicator of oxidative stress, and our study suggests that oxidative stress is associated with pathogenesis or progression of IgAN. Furthermore, tonsillectomy may reduce oxidative stress and lead to improvement of glomerulonephritis in IgAN patients.
In this study, serum TRX levels were positively correlated with serum BUN and uric acid, and were negatively correlated with eGFR; these markers are associated with IgAN severity (Table 3 ). In addition, serum TRX levels seem to be positively correlated with the histological findings ( Fig. 2 and Table 3 ). Intrarenal oxidative stress is increased in IgAN patients at early stages (19) , and increased levels of an oxidative stress marker, advanced oxidation protein products (AOPPs), have also been reported to be significantly associated with proteinuria and disease progression in IgAN patients (2, 20) . Under oxidative stress, antioxidant enzymes such as TRX are induced in several diseases, including liver disease. Furthermore, serum TRX levels were not correlated with u-TRX/u-Cr (Table 2) ; the increase in serum TRX seems not to be due to a decrease in its renal clearance in patients with IgAN. These results suggest that an imbalance between free radical generation and activation of antioxidant defense mechanisms may be present in IgAN.
In the present study, serum levels of MnSOD, another oxidative stress marker, were similar in IgAN patients and healthy subjects, and did not change after tonsillectomy. We previously reported that serum TRX levels were not correlated with serum MnSOD levels in patients with hepatitis C virus-related hepatocellular carcinoma (9) . We speculate that the sources of serum TRX and MnSOD in IgAN are different from those in liver disease, and serum TRX levels are a sensitive oxidative stress marker in IgAN whereas MnSOD is not. Immunohistochemical analysis for TRX in several organs, such as renal tissue, tonsils, and liver, and the evaluation of other serum oxidative stress markers are needed in IgAN patients. In contrast, serum TRX levels in 14 patients with lupus nephritis or purpura nephritis were higher compared to those in healthy controls, and similar to those in IgAN (data not shown). Although serum TRX seems not to be specific for IgAN among mesangial proliferative glomerulonephritis, serum TRX levels reflect the clinical data and may in part be associated with tonsillectomy. Therefore, serum TRX still may be a potential biomarker for IgAN, although further examination in a large number of patients with other forms of mesangial proliferative glomerulonephritis is needed.
Tonsillectomy is thought to be effective in improving renal function in IgAN patients (14) . Akagi et al reported that tonsillectomy leads to favorable long-term outcomes in IgAN patients (21) . Although the mechanism by which tonsillectomy is an effective treatment for IgAN is not fully understood, the reduction of IgA mesangial deposition after tonsillectomy may in part explain the mechanism of this treatment. The present study indicates that reduction of oxidative stress assessed by serum TRX levels is another mechanism by which tonsillectomy may function. In addition, decreases of serum TRX were small after tonsillectomy, and TRX was not reduced to the levels seen in healthy subjects in our study. Wang et al, based on their meta-analysis, concluded that whereas neither tonsillectomy nor steroid treatment alone increased remission rates in IgAN patients, tonsillectomy combined with either normal steroid or steroid pulse treatment resulted in higher remission rates with favorable long-term efficacy (22) . We speculate that tonsillectomy is effective in reducing oxidative stress in IgAN patients, but that this effect is small and combination therapy with tonsillectomy plus steroid-based treatment may be necessary to obtain significant reduction of oxidative stress and favorable long-term outcome. In addition, three patients with lower levels of serum TRX exhibited an increase in serum TRX after tonsillectomy in this study (Fig. 3) . These changes might be a result of other transient disease, such as acute inflammatory disease, although the exact cause was not elucidated. Evaluation of serum TRX levels in patients with IgAN should therefore be carefully performed.
Gene analysis did not show a clear association between oxidative stress in tonsils and the IgAN pathogenesis (23) . In contrast, Kusano et al reported that the prevalence of tonsillar H. pylori in IgAN patients was 14 (100%) of 14 patients, and was significantly higher than in patients with recurrent pharyngotonsillitis (24) . Anti-H. pylori IgA antibody in the serum of IgAN patients was more frequent and levels were higher compared to controls without renal disease (25) , and this antibody showed positive staining in the glomerular capillary walls (26) . Basal levels of ROS were greater in epithelial cells isolated from gastric mucosal biopsy specimens from H. pylori-infected subjects than in cells from uninfected individuals (27) . It is possible that immune complexes formed by H. pylori and this antibody in the palatine tonsils are a potential cause of IgAN pathogenesis (24) , and tonsillectomy may reduce these complexes, leading to attenuation of the severity of IgAN accompanied by the reduction of serum TRX levels in an indirect manner.
In conclusion, the present study indicated that serum TRX levels are not only higher in patients with IgAN, but also are correlated with disease severity in IgAN patients. In addition, the effects of tonsillectomy in IgAN patients may be associated with a reduction of oxidative stress. The immunohistochemical analyses of TRX in several tissue types, including renal tissue, as well as long-term observation, undoubtedly have value in further understanding IgAN pathogenesis.
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